Doceree, a healthtech SaaS startup, has secured $35 million in its Series B funding round, led by Creageis and other investors like Eight Roads Ventures and F-Prime Capital. The funding will be used to enhance product development, advance technologies, expand globally, and increase Doceree's workforce. The company simplifies marketing for pharmaceutical and medical device companies using proprietary tools for healthcare professionals.

Doceree is a global platform that connects life sciences brands with healthcare providers through digital and point-of-care platforms, enabling personalized messaging at scale. It has expanded its services to Africa, Southeast Asia, and the Gulf Cooperation Council.

The startup has announced that a series of smart and connected solutions from Doceree's product lineup are set to be launched in the coming months. These innovative products are expected to bring about a transformative impact on the global ecosystem. Previously, in April of the preceding year, the startup successfully raised $11 million in its Series A funding round, with Eight Roads Ventures taking the lead in the investment, accompanied by participation from F-Prime Capital and Alkemi Growth Capital.

"Given we are a technology-driven platform, we will further invest on artificial intelligence and machine learning technologies to make the product even more intelligent," Jain said.

Doceree has created ESPYIAN, a proprietary identity resolution technology platform, designed to establish a database of verified and genuine medical and healthcare professionals. The recent leader of Doceree's funding round, Creagis, also revealed the successful closure of its inaugural $425 million (INR 3,529 Crore) fund last week, earmarked for investments in domestic startups.